PBD6A, a form of Zellweger syndrome, is characterized by neurodevelopmental abnormalities (neuronal migration defects, leukodystrophy, cognitive and psychomotor delay, profound dystonia, and seizures), skeletal abnormalities (craniofacial abnormalities and achondroplasia), and multisystem impairments (eyesight, hearing, liver, and kidney impairments), and the survival of affected infants is usually less than one year [7,15,30–32]. Here, PEX10 is linked to leukodystrophy.